Applying immunotherapy in clinical practice for patients with early-stage NSCLC
Update: 2025-06-23
Description
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
- Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
